Reverse-transcriptase Real-time PCR in the Diagnostic Strategy for Invasive Infections Caused by

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2024 Oct 24

PMID 39445834

Authors

Charles Gibert

Pauline Tirard-Collet

Charline Miossec

Damien Dupont

Florence Persat

Martine Wallon

Florence Ader

Gilles Devouassoux

Sophie Ducastelle

Helene Labussiere-Wallet

Sylvie Paulus

Celine Guichon

Anne-Claire Lukaszewicz

Jean-Christophe Richard

Florent Wallet

Alexandre Alanio

Meja Rabodonirina

Jean Menotti

Affiliations

Soon will be listed here.

Abstract

The aim was to develop an RT-qPCR targeting and compare its performance to that of qPCR for the diagnosis of invasive aspergillosis (IA). Samples from patients of the Lyon University hospitals for whom a suspicion of IA led to the realization of an qPCR molecular diagnostic test over a 2-year period were included. The patients were classified according to the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC-MSGERC) criteria for suspected IA; RT-qPCR and qPCR assays were performed on all included samples. The sensitivities and specificities of RT-qPCR and qPCR were calculated and compared using the results of the EORTC-MSGERC classification as reference. The cycle threshold (Ct) results were compared according to IA classification and sample type. Among the 193 samples analyzed, 91 were classified as IA excluded, 46 as possible IA, 53 as probable IA, and 3 as proven IA. For all sample types, RT-qPCR was significantly more sensitive than qPCR for all IA classifications with an additional 17/102 samples detected (-value < 0.01). For plasma samples, sensitivity was significantly higher and specificity significantly lower using RT-qPCR for all IA classifications (-value < 0.001). The mean Ct obtained with RT-qPCR were significantly lower than those obtained with qPCR for all IA classifications and all sample types (-value < 0.001 and -value < 0.0001, respectively). RT-qPCR presents a higher sensitivity than qPCR for the diagnosis of IA due to , particularly in samples with an intrinsically low fungal load.IMPORTANCE belongs to the critical priority group of the World Health Organization fungal priority pathogens list. Invasive aspergillosis (IA) is a life-threatening infection with poor prognosis and challenging diagnosis. PCR has been integrated into the 2020 European Organization for Research and Treatment of Cancer/Mycoses Study Group consensus definitions for IA diagnosis. However, due to frequent low fungal burdens, its sensitivity needs to be improved. This work presents an innovative method for detecting total nucleic acids, corresponding to both ribosomal RNA and DNA, that enables IA diagnosis with greater sensitivity than conventional techniques, especially in non-invasive samples such as blood, enhancing the monitoring of this infection in high-risk patients.

References

Delliere S, Hamane S, Aissaoui N, Gits-Muselli M, Bretagne S, Alanio A . Increased sensitivity of a new commercial reverse transcriptase-quantitative PCR for the detection of Pneumocystis jirovecii in respiratory specimens. Med Mycol. 2021; 59(8):845-848. DOI: 10.1093/mmy/myab029. View

Mikulska M, Furfaro E, De Carolis E, Drago E, Pulzato I, Borghesi M . Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan. Med Mycol. 2019; 57(8):987-996. PMC: 7107636. DOI: 10.1093/mmy/myz002. View

Bader O . MALDI-TOF-MS-based species identification and typing approaches in medical mycology. Proteomics. 2013; 13(5):788-99. DOI: 10.1002/pmic.201200468. View

Koehler P, Bassetti M, Chakrabarti A, Chen S, Colombo A, Hoenigl M . Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020; 21(6):e149-e162. PMC: 7833078. DOI: 10.1016/S1473-3099(20)30847-1. View

Kanj A, Abdallah N, Soubani A . The spectrum of pulmonary aspergillosis. Respir Med. 2018; 141:121-131. DOI: 10.1016/j.rmed.2018.06.029. View

Imbert S, Brossas J, Palous M, Joly I, Meyer I, Fekkar A . Performance of Aspergillus PCR in cerebrospinal fluid for the diagnosis of cerebral aspergillosis. Clin Microbiol Infect. 2017; 23(11):889.e1-889.e4. DOI: 10.1016/j.cmi.2017.06.012. View

Dupont D, Menotti J, Turc J, Miossec C, Wallet F, Richard J . Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19). Med Mycol. 2020; 59(1):110-114. PMC: 7499748. DOI: 10.1093/mmy/myaa078. View

Ledoux M, Guffroy B, Nivoix Y, Simand C, Herbrecht R . Invasive Pulmonary Aspergillosis. Semin Respir Crit Care Med. 2020; 41(1):80-98. DOI: 10.1055/s-0039-3401990. View

Jani K, McMillen T, Morjaria S, Babady N . Performance of the sōna Galactomannan Lateral Flow Assay in a Cancer Patient Population. J Clin Microbiol. 2021; 59(9):e0059821. PMC: 8373023. DOI: 10.1128/JCM.00598-21. View

10.

de Macedo P, Sturny-Leclere A, Freitas D, Ghelfenstein-Ferreira T, Gutierrez-Galhardo M, Almeida M . Development and validation of a new quantitative reverse transcription PCR assay for the diagnosis of human sporotrichosis. Med Mycol. 2023; 61(7). DOI: 10.1093/mmy/myad063. View

11.

Hoenigl M, Prattes J, Spiess B, Wagner J, Prueller F, Raggam R . Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2014; 52(6):2039-45. PMC: 4042784. DOI: 10.1128/JCM.00467-14. View

12.

Morton C, De Luca A, Romani L, Rogers T . RT-qPCR detection of Aspergillus fumigatus RNA in vitro and in a murine model of invasive aspergillosis utilizing the PAXgene® and Tempus™ RNA stabilization systems. Med Mycol. 2012; 50(6):661-6. DOI: 10.3109/13693786.2011.652200. View

13.

Simoneau E, Kelly M, Labbe A, Roy J, Laverdiere M . What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience. Bone Marrow Transplant. 2004; 35(3):303-6. DOI: 10.1038/sj.bmt.1704793. View

14.

Guegan H, Chevrier S, Belleguic C, Deneuville E, Robert-Gangneux F, Gangneux J . Performance of Molecular Approaches for Detection and Azole Resistance Surveillance in Cystic Fibrosis. Front Microbiol. 2018; 9:531. PMC: 5880881. DOI: 10.3389/fmicb.2018.00531. View

15.

Normand A, Becker P, Gabriel F, Cassagne C, Accoceberry I, Gari-Toussaint M . Validation of a New Web Application for Identification of Fungi by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol. 2017; 55(9):2661-2670. PMC: 5648703. DOI: 10.1128/JCM.00263-17. View

16.

Fraczek M, Zhao C, Dineen L, Lebedinec R, Bowyer P, Bromley M . Fast and Reliable PCR Amplification from Aspergillus fumigatus Spore Suspension Without Traditional DNA Extraction. Curr Protoc Microbiol. 2019; 54(1):e89. PMC: 6916316. DOI: 10.1002/cpmc.89. View

17.

Delliere S, Dudoignon E, Voicu S, Collet M, Fodil S, Plaud B . Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?. J Clin Microbiol. 2022; 60(3):e0216921. PMC: 8925884. DOI: 10.1128/JCM.02169-21. View

18.

Huygens S, Dunbar A, Buil J, Klaassen C, Verweij P, van Dijk K . Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study. Clin Infect Dis. 2023; 77(1):38-45. PMC: 10320047. DOI: 10.1093/cid/ciad141. View

19.

Alanio A, Gits-Muselli M, Lanternier F, Sturny-Leclere A, Benazra M, Hamane S . Evaluation of a New Histoplasma spp. Quantitative RT-PCR Assay. J Mol Diagn. 2021; 23(6):698-709. DOI: 10.1016/j.jmoldx.2021.02.007. View

20.

Lamoth F, Calandra T . Pulmonary aspergillosis: diagnosis and treatment. Eur Respir Rev. 2022; 31(166). PMC: 9724826. DOI: 10.1183/16000617.0114-2022. View